4978.T Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 02:15):

Stats
Today's Volume	247 000
Average Volume	545 120
Market Cap	12.01B
EPS	¥0 ( 2024-02-08 )
Next earnings date	( ¥-3.62 ) 2024-05-10
Last Dividend	¥0 ( N/A )
Next Dividend	¥0 ( N/A )
P/E	-52.33
ATR14	¥0.144 (0.11%)

Volume Correlation

Long: 0.07 (neutral)

Short: 0.13 (neutral)

Signal:(48.409) Neutral

ReproCELL Incorporated Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ReproCELL Incorporated Correlation - Currency/Commodity

-0.02
( neutral )

0.29
( neutral )

0.00
( neutral )

-0.07
( neutral )

-0.48
( neutral )

0.58
( weak )

ReproCELL Incorporated Financials

Annual	2022
Revenue:	¥2.95B
Gross Profit:	¥1.14B (38.64 %)
EPS:	¥-3.62

FY	2022
Revenue:	¥2.95B
Gross Profit:	¥1.14B (38.64 %)
EPS:	¥-3.62

FY	2022
Revenue:	¥2.23B
Gross Profit:	¥803.44M (35.96 %)
EPS:	¥-7.57

FY	2021
Revenue:	¥1.29B
Gross Profit:	¥482.70M (37.53 %)
EPS:	¥-11.38

Financial Reports:

No articles found.

ReproCELL Incorporated

ReproCELL Incorporated operates as a stem cell research company in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, pluripotent stem cell culture media, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, and induced neurons; and 3D cell culture; and labware. The company also provides preclinical genomics, stem cell research, drug efficacy, safety, & ADME, human tissue samples, therapeutic pipeline, clinical laboratory services, clinical diagnostic services, and gmp ipsc master cell bank services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.